Selective and Permanent Occlusion of the Middle Cerebral Artery in Rats: An Experimental Approach for Studying Motor and Spatial Memory Deficits
March 20th, 2026
The objective of this study was to establish a reproducible method for performing a craniectomy followed by permanent, selective middle cerebral artery occlusion in rats for application in experimental studies of motor and spatial memory deficits.
A rat model of selective permanent MCA occlusion was developed to study motor and spatial memory deficits. Many stroke models are less selective, so this protocol allows direct vessel viewing and precise distal MCA occlusion. To begin, assemble the clean sterile surgical instruments around the microscope stage covered with a sterile cloth.
Expose the left lateral side of the anesthetized Worcester rat placed in 180 degree lateral decubitus on the padded microscope stage with the head supported by a soft roll. Secure the head with adhesive tape. Apply lubricating eye drops.
Tape the eyelids closed. Recheck the rectal temperature to ensure it remains within the ideal range of approximately 37 degrees Celsius. Adjust the heating source if needed.
Perform trichotomy over a 1.6 by 0.5 centimeter region between the lateral canthus and the tragus using a mini trichotomizer or razor blade. Disinfect the shaved area with 2%chlorhexidine scrub, followed by 0.2%aqueous chlorhexidine. Use a sterile scalpel blade to make a one centimeter skin and subcutaneous incision, maintaining a 0.3 centimeter margin posterior to the lateral canthus and anterior to the tragus.
Use hemostatic forceps to retract the skin and subcutaneous layer. After identifying the middle temporal branch of the superficial temporal vessels, coagulate the vessel with electrocautery. Using a freer elevator, palpate the zygomatic arch.
Incise the temporal muscle fascia longitudinally. Dissect the temporal muscle cranially and caudally to expose the temporal and frontal bones and a part of the mass seeder muscle. Isolate the zygomatic arch longitudinally.
Remove an approximately 0.5 centimeter segment of the zygomatic arch. Take appropriate precautions while performing the procedure. Use a round diamond-coated burr to drill the lateral temporal bone immediately posterior to the zygomatic arch removal site with intermittent 0.9%saline irrigation.
During drilling, leave a thin residual bony layer attached to the dura mater. Use Halsted forceps to gently remove the remaining attached fragments. Use an ultrafine needle to open the dura mater.
Identify the inferior cerebral vein, the middle cerebral artery, or MCA, and the basal and thickest MCA branch at the center. Use a fine needle holder to pass a non-absorbable 8.0 polypropylene suture around the MCA, and occlude the vessel by tying three knots around it. After confirming the absence of downstream blood flow, use the ultra-fine needle to check for additional MCA branches to ligate if present.
Irrigate the cavity with saline. Perform hemostasis with electrocautery or gentle compression. After MCA occlusion and dural closure, reapproximate the deep muscle layer and suture the temporal muscle fascia using absorbable 4-O suture.
Use absorbable 4-0 polyglactin 910 sutures to stitch the subcutaneous layer and the skin layer in a continuous pattern. Conduct postoperative evaluation across specific days. Motor function scores in the postural test on postoperative day seven were significantly higher in MCA occlusion animals compared to sham animals.
MCA occlusion animals showed reduced exploration of the relocated object on postoperative day eight compared to sham animals. This protocol helps researchers study selective cortical ischemia and its effects on motor function and spatial memory. The main challenge is doing the craniectomy safely and identifying the middle cerebral artery correctly.
Future studies can use this model to test treatments and study long-term functional and histological outcomes.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a reproducible and effective protocol for inducing selective permanent occlusion of the middle cerebral artery (MCA) in rats via craniectomy. The method aims to closely mimic human ischemic stroke (IS) conditions, facilitating research into motor and spatial memory deficits and supporting the development of novel adjuvant therapies.
Key Study Components
Area of Science
- Neuroscience
- Stroke research
- Experimental neurology
Background
- Ischemic stroke is a major clinical concern requiring improved experimental models.
- Rats are commonly used due to similarities in cerebral vascular anatomy with humans.
- Existing models often lack selectivity in arterial occlusion, limiting translational relevance.
- Standardized, reproducible methods are needed for reliable assessment of stroke-induced deficits.
Purpose of Study
- To establish a reproducible rat model of selective MCA occlusion via craniectomy.
- To standardize the procedure for broader application in stroke research.
- To assess the model's effectiveness in producing motor and spatial memory deficits.
Methods Used
- Wistar rats divided into SHAM (craniectomy only) and MCAO (craniectomy plus MCA occlusion) groups.
- Detailed surgical protocol including preoperative preparation, anesthesia, positioning, craniectomy, selective MCA occlusion, and closure.
- Behavioral assessment using postural and object location recognition memory tests on postoperative days 7 and 8.
- Histological analysis of brain tissue with Nissl staining to confirm lesion selectivity.
Main Results
- MCAO group exhibited significant deficits in postural (p = 0.015) and memory (p < 0.001) tests compared to SHAM.
- Histology confirmed selective injury to hippocampal-associated cortical areas (perirhinal, entorhinal, piriform cortices, and external capsule).
- Deeper brain structures remained preserved, demonstrating the selectivity of the occlusion.
- The protocol was reproducible and technically accessible.
Conclusions
- The described method reliably induces selective MCA ischemia in rats.
- It provides a valid and accessible tool for experimental studies of ischemic stroke.
- This model supports investigation of pathophysiological and therapeutic mechanisms relevant to human stroke.
Frequently Asked Questions
Executive Industry Relevance
Selective and permanent occlusion of the middle cerebral artery (MCA) in rats provides a standardized preclinical model for ischemic stroke, enabling robust evaluation of motor and spatial memory deficits. This reproducible approach enhances predictive confidence for translational research by closely mimicking human stroke pathology. The model supports risk-adjusted advancement of neurotherapeutic candidates and informs early go/no-go decisions in the discovery pipeline.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of therapeutic hypotheses targeting ischemic injury mechanisms.
- Supports functional validation of neuroprotective targets in a disease-relevant system.
- Facilitates mechanistic de-risking by isolating cortical injury while preserving deeper structures.
- Provides a platform for portfolio triage based on translationally relevant endpoints.
Screening & Assay Development
- Standardizes induction of selective ischemic injury for downstream behavioral and histological assays.
- Ensures reproducibility and quantitative assessment of motor and memory deficits.
- Enables reliable evaluation of candidate compounds in a validated preclinical context.
- Supports scalability and cross-study comparability for screening workflows.
Translational & Preclinical Research
- Aligns with human stroke pathology for improved translational biomarker development.
- Maintains continuity from early discovery through preclinical efficacy validation.
- Reduces biological risk by providing consistent, selective injury patterns for therapeutic testing.
- Enables risk-adjusted advancement decisions based on robust functional and histological outputs.
Pipeline & Workflow Integration
This selective MCA occlusion model integrates into the discovery-to-preclinical continuum, supporting target validation, lead identification, and translational research for ischemic stroke.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification in stroke mechanisms.
- Screening: Provides reproducible, quantitative behavioral and histological readouts for compound evaluation.
- Analytics: Enables statistical comparison of motor and memory outcomes across experimental groups.
- Translational Research: Aligns preclinical findings with human-relevant injury patterns and endpoints.
- Enterprise Reuse: Offers a standardized, reusable platform for diverse neurotherapeutic research initiatives.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in stroke research.
- Operational Value: Delivers standardized, reproducible, and scalable preclinical workflows.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in neurotherapeutic development.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of stroke-related assets.
Implementation Considerations
- Requires surgical expertise in craniectomy and vascular occlusion techniques.
- Necessitates access to behavioral testing and histological analysis infrastructure.
- Demands cross-team standardization for reproducibility and data comparability.
- Adaptable to various rat strains but may require protocol optimization for other models.
- Technical limitations include the need for precise arterial targeting to ensure selectivity.
